20:18:52 Europe / Stockholm

Kalender

2024-08-30 Kvartalsrapport 2024-Q2
2024-04-11 Ordinarie utdelning MONSO 0.00 DKK
2024-04-10 Årsstämma 2024
2024-03-06 Bokslutskommuniké 2023
2023-09-07 Kvartalsrapport 2023-Q2
2023-04-13 Ordinarie utdelning MONSO 0.00 DKK
2023-04-12 Årsstämma 2023
2023-03-08 Bokslutskommuniké 2022
2022-12-20 Extra Bolagsstämma 2022
2022-08-31 Kvartalsrapport 2022-Q2
2022-04-07 Ordinarie utdelning MONSO 0.00 DKK
2022-04-06 Årsstämma 2022
2022-03-09 Bokslutskommuniké 2021
2021-11-16 Extra Bolagsstämma 2021
2021-08-26 Kvartalsrapport 2021-Q2
2021-04-15 Ordinarie utdelning MONSO 0.00 DKK
2021-04-14 Årsstämma 2021
2021-03-10 Bokslutskommuniké 2020

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorInformationsteknik
IndustriProgramvara
Monsenso är verksamt inom IT-sektorn. Bolaget är specialiserat inom tillhandahållandet av digitala uppföljningssystem för vård och omsorg, samt sjukhus. Lösningarna är mjukvarubaserade och används huvudsakligen för uppföljning av patienters hälsotillstånd, samt för intern bevakning och analys. Störst verksamhet återfinns inom den nordiska marknaden. Huvudkontoret ligger i Köpenhamn.
2021-09-13 12:02:11

13.9.2021 12:02:11 CEST | Monsenso | Company Announcement

Company announcement no. 16-2021

Copenhagen, 2021.09.13

Monsenso changes its expectations to revenue in 2021 to DKK 7-8m.

Despite new orders in Denmark as well as in the UK, two new larger customer cases will not be closed as expected in the company’s favour this year. The expectations for revenue in the current financial year are therefore adjusted to DKK 7-8m against previously announced DKK 9-10m. Due to Covid-19 and the fact that revenue is still dependent on the progress in a number of large customer projects, expectations are subject to uncertainty.

Expectations to EBITDA is adjusted to DKK -5.5m to -6.5m from previously DKK -5m to -6m. The relatively modest change in EBITDA is caused by cost reduction and postponement.

The markets for digital mental health and real-world data collection continue to be very attractive and Monsenso retains its ambitions to create international growth. With expansion of the technical and commercial organisation, including establishing a sales organisation in the UK, Monsenso is currently building the required sales pipeline that is the foundation for future growth.

Any inquiries regarding this notice should be directed to:

Monsenso

CEO
Thomas Lethenborg
Tlf. +45 21 29 88 27
E-mail: lethenborg@monsenso.com 

Chairman of the board
Maria Hjorth
Tel. +45 25 55 63 39
E-mail: maria.hjorth@gmail.com

Certified Adviser

Norden CEF ApS
John Norden
Tlf. +45 20 72 02 00
E-mail: jn@nordencef.dk

About Monsenso

Monsenso is an innovative technology company offering a digital health solution for mental health and behavioral disorders. Our mission is to help provide better mental health to more people at lower costs. Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit  www.monsenso.com

Attachments